These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17607530)
1. Levetiracetam use in critically ill patients. Szaflarski JP; Meckler JM; Szaflarski M; Shutter LA; Privitera MD; Yates SL Neurocrit Care; 2007; 7(2):140-7. PubMed ID: 17607530 [TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Szaflarski JP; Sangha KS; Lindsell CJ; Shutter LA Neurocrit Care; 2010 Apr; 12(2):165-72. PubMed ID: 19898966 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam monotherapy--outcomes from an epilepsy clinic. Stephen LJ; Kelly K; Parker P; Brodie MJ Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583 [TBL] [Abstract][Full Text] [Related]
4. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam. Kruer RM; Harris LH; Goodwin H; Kornbluth J; Thomas KP; Slater LA; Haut ER J Crit Care; 2013 Oct; 28(5):883.e9-13. PubMed ID: 23566730 [TBL] [Abstract][Full Text] [Related]
5. Levetiracetam monotherapy for elderly patients with epilepsy. Alsaadi TM; Koopmans S; Apperson M; Farias S Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184 [TBL] [Abstract][Full Text] [Related]
6. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy. Abou-Khalil B; Hemdal P; Privitera MD Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078 [TBL] [Abstract][Full Text] [Related]
7. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Rossetti AO; Jeckelmann S; Novy J; Roth P; Weller M; Stupp R Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644 [TBL] [Abstract][Full Text] [Related]
8. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651 [TBL] [Abstract][Full Text] [Related]
9. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820 [TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors. Newton HB; Dalton J; Goldlust S; Pearl D J Neurooncol; 2007 Sep; 84(3):293-6. PubMed ID: 17431542 [TBL] [Abstract][Full Text] [Related]
11. Use of levetiracetam in hospitalized patients. Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722 [TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study. Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275 [TBL] [Abstract][Full Text] [Related]
13. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168 [TBL] [Abstract][Full Text] [Related]
15. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study. Iuchi T; Kuwabara K; Matsumoto M; Kawasaki K; Hasegawa Y; Sakaida T J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1158-62. PubMed ID: 25511789 [TBL] [Abstract][Full Text] [Related]
16. Impact of anti-epileptic drug choice on discharge in acute traumatic brain injury patients. Harris L; Hateley S; Tsang KT; Wilson M; Seemungal BM J Neurol; 2020 Jun; 267(6):1774-1779. PubMed ID: 32130500 [TBL] [Abstract][Full Text] [Related]
17. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis. Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526 [TBL] [Abstract][Full Text] [Related]
19. Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life. Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Muti P J Neurooncol; 2011 Aug; 104(1):205-14. PubMed ID: 21107994 [TBL] [Abstract][Full Text] [Related]
20. Levetiracetam therapy in patients with brain tumour and epilepsy. Maschio M; Albani F; Baruzzi A; Zarabla A; Dinapoli L; Pace A; Pompili A; Carapella CM; Occhipinti E; Jandolo B J Neurooncol; 2006 Oct; 80(1):97-100. PubMed ID: 16685465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]